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Background: To comprehend the relationship between the
mycoplasma infection and systemic lupus erythematosus.
Methods: Mycoplasma hominis, Ureaplasma urealyticum,
and Mycoplasma fermentans were studied by nested
polymerase chain reaction in eyelid, threat, urethra and
blood of 80 patients with systemic lupus erythematosus.
Result: 65.0% of patients with systemic lupus erythematosus
showed the mycoplasma infection at one or more positions
(c2 = 17.33, P< 0.01), in which 12.5% of patients with that
showed the mycoplasma infection at two positions and
6.2% of patients showed the mycoplasma infection at three
positions. 22.4% of patients showed the mycoplasma hominis
infection in the threat (c2 = 3.89, P< 0.05), and 28.2% of
patients showed the Ureaplasma urealyticum infection in
the urethra (c2 = 5.20, P< 0.05).
Conclusion: There were mycoplasmas infected in several
positions of patients with systemic lupus erythematosus.
The risk of contracting systemic lupus erythematosus for
the subject infected with mycoplasma was 16 times for the
control.
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Objective: To analyze factors correlative with prognosis of
patients with varicella.
Methods: Data of 166 patients with varicella treated in
The Third Afﬁliated Hospital of Sun Yat-sen University were
collected. All the patients were observed for one week.
Correlative analysis of prognosis (recovery, improvement,
no change, death) of patients with varicella and 16
variables were done. These variables included sex, age,
patient sources, seizures season, disease course, history
of contacting with varicella patients, underlying disease,
hormone usage, fever, fever course, clinical symptoms
except chickenpox (sore throat, cough, abdominal pain
or diarrhea, etc.), complications, bacterial infections,
antibiotics usage, Aciclovir usage and ribavirin usage. All
the data was carried out with software SPSS 13.0. Chi
square test was used to compare observed rates, while
Logistic regression methods was used to analyze correlation
between prognosis and observed factors.
Results: Among 166 patients with varicella, 110 cases
(66.3%) recovered completely, 41 cases (24.7%) were
improved, pathogenetic condition of 9 cases (5.4%) had
not changed, 6 (3.6%) were dead before discharge
from hospital. Single factor analysis demonstrated that
disease course, underlying disease, hormone usage,
fever, clinical symptoms except chickenpox and Aciclovir
usage were correlative factors to prognosis of patients
with varicella (c2 = 7.869 25.934, P = 0.000 0.049). The
multivariate Logistic regression analysis suggested that
only disease course (OR = 12.284, P = 0.000), hormone usage
(OR = 5.396, P= 0.020) and Aciclovir usage (OR = 8.486,
P = 0.004) were correlative factors to prognosis. Prognosis
of these patients with disease course above 10 days,
hormone usage and without Aciclovir were worse than that
of others.
Conclusions: Disease course, hormone usage and Aciclovir
usage were correlative factors to prognosis of patients
with varicella. These results would contribute to better
treatment to patients with varicella.
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Background: Nanosilver has been showed superior
antimicrobial activity towards various microorganisms. The
aim of this study was to determine in-vitro activity of
Nanosilver as a disinfectant and the effect of Nanosilver on
environmental bacterial and fungal colonization onto the
hospital surfaces.
Methods: At ﬁrst, sampling, culture and sensitivity
pattern of some surfaces have been done. Next, in-vitro
antimicrobial activity of antiseptics against microorganisms
was assessed by using disinfectants included Nanosilver,
Deconex 50 AF and Descocid. Finally, assessment of
disinfectant activity on environmental bacterial & fungal
colonisation and the duration of effect were performed in
three rooms of the infectious diseases ward.
Results: In-vitro study showed that S. aureus and coagulase
negative Staphylococcus were eradicated after 5 minutes
contact with each of diainfectants. All of used disinfectants
could eradicate Pseudomonas after 5 minutes but Nanosilver
5ppm. Bacillus was eradicated by Deconex 2% within
30 minutes and by Descocid 2% and 4% within 5 minutes
but Nanosilver effect was different. Aspergillosis and
Penicillium were eradicated by Nanosilver 80, 100, 150 ppm,
Deconex 2%, Descocid 2% and 4% after 5 minutes contact.
Assessment of disinfectant activity on the environmental
surfaces showed a signiﬁcant difference between the mean
amounts of organisms before and after washing in paired
T-test.
Conclusion: Washing of surfaces at least twice daily can
be suitable to eradicate environmental Staphylococcus,
bacillus and fungi. We must consider recontamination of
hospital surfaces which can occur normally.
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Background: The novel inﬂuenza A (H1N1) virus is now
rapidly spreading across the world. Early detection is one of
the most effective measures to prevent further transmission
of the virus. However, there is no report regarding the type
of specimens that yield the best result of the Inﬂuenza virus
detection and sufﬁcient amount of cells in the sample.
Methods: The RNase P real time PCR were performed using
four types of specimens, including Nasopharyngeal swab
(NPS), Throat swab (TS), Nasal swab (NS) and Tracheal
aspiration (TA). The RNase P Ct value were then determined
